- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Juried awards offered for additions to the history
Evident Technologies, the leader in the commercial development of advanced quantum dot nanomaterials, today announced that it launched a living online history of early work in the field of quantum dot technology, "The Quantum Dot History Project," which is a representative overview of key research and researchers from 1960-1996.
Evident welcomes the submission of additional entries and will award a $500 Amazon gift certificate for the earliest published research entry accepted and an Apple iPod nano for each of the next two earliest published entries accepted. In appreciation for the efforts of individuals submitting entries, the company will provide them with a $10 Amazon gift certificate for each novel history addition accepted. Deadline for submission is January 31, 2006, and is open to all. To view the history or enter the contest visit www.evidenttech.com/.
"Quantum dots are a versatile form of semiconductors that mean scientists and engineers are no longer shackled by the fixed properties of nature. With quantum dots, new materials can be engineered to fit a need, solve a problem and create new products or even markets," said Clinton Ballinger, Ph.D., Chief Executive Officer of Evident Technologies.
"We are publishing this overview as our commitment to pioneers who did the early work in this field and to future scientists and developers who want to use quantum dots to create revolutionary change," said Ballinger. "The early semiconductor work of Bell Labs in 1947 led to a whole revolution in electronics, forever changing our world. An open and free flowing exchange of ideas and knowledge in our field, which our overview celebrates, could help improve so many areas of our life."
"I am very pleased to see this history of nanocrystals on-line as a ready resource for current and future researchers," said Dr. Alexander Efros, currently at the United States Naval Research Laboratory and one of the earliest discoverers of quantum dots. "When we discovered quantum confinement in nanocrystals in the early 80's, we knew this would be an exciting area of scientific exploration and discovery. I am personally excited to see today's pioneers at Evident translating quantum dot technology into product applications ranging from life science research to solar cells to anti-counterfeiting."
Dr. Margaret Hines, Head of Nanomaterials R&D at Evident Technologies, commented: "Explorations into the science of quantum dots began decades ago. The technology is finally gaining momentum. It is inspiring to see this presentation of the rich history of quantum dots. The web site is easily accessible and will interest scientists at all levels and spur further innovation."
About Evident Technologies:
Evident is the leading developer and commercial source for a wide range of quantum dot-based semiconductor nanomaterials. These can be used to engineer new materials and create often revolutionary products across many diverse markets. We partner with a growing number of companies, research institutions and organizations. We have over 500 customers and dozens of products in development, testing or on the market for commercial sale. And, through our information-rich website, www.evidenttech.com, and projects like this history booklet, we are committed to expanding the awareness and appreciation of our field.
For more information, please click here
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Biosensors: Distance makes the signal grow stronger March 1st, 2017
Smart multi-layered magnetic material acts as an electric switch: New study reveals characteristic of islands of magnetic metals between vacuum gaps, displaying tunnelling electric current March 1st, 2017
NovAliX Turns to High-Resolution Cryo-Transmission Electron Microscopy for Pre-Clinical Drug Discovery Research: Thermo Fisher Scientificís Cryo-TEM provides critical information for small molecule and biologic drug discovery February 28th, 2017